BamSEC and AlphaSense Join Forces
Learn More

Ambrx Biopharma Inc.

Formerly NASDAQ: AMAM
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 16 pages Second Amended and Restated Executive Employment Agreement
12/34/56
EX-10.7
from 10-Q 4 pages Ambrx Biopharma, Inc. Non-Employee Director Compensation Policy Adopted and Effective: June 7, 2023 Amended and Restated: October 11, 2023
12/34/56
EX-10.6
from 10-Q 27 pages Ambrx Biopharma, Inc. Second Amended and Restated 2016 Equity Incentive Plan (As Amended and Restated Effective October 11, 2023) Article 1. Purpose
12/34/56
EX-10.5
from 10-Q 31 pages Ambrx Biopharma, Inc. Amended and Restated 2021 Equity Incentive Plan Adopted by the Board of Directors: June 3, 2021 Approved by the Shareholders: June 9, 2021 as Hereby Amended and Restated, October 11, 2023
12/34/56
EX-10.4
from 10-Q 11 pages Ambrx Biopharma, Inc. Amended and Restated 2021 Employee Share Purchase Plan Adopted by the Board of Directors: June 3, 2021 Approved by the Shareholders: June 9, 2021 as Amended and Restated as of October 11, 2023
12/34/56
EX-10.3
from 10-Q 15 pages Amended and Restated Executive Employment Agreement
12/34/56
EX-10.2
from 8-K12G3 13 pages Amended and Restated Executive Employment Agreement
12/34/56
EX-10.1
from 8-K12G3 14 pages Amended and Restated Executive Employment Agreement
12/34/56
EX-10.26
from S-4/A 14 pages Amended and Restated Executive Employment Agreement
12/34/56
EX-10.19
from S-4/A 10 pages Ambrx Biopharma, Inc. Indemnification Agreement
12/34/56
EX-10.8
from S-4/A 3 pages Ambrx Biopharma, Inc. Non-Employee Director Compensation Policy Adopted and Effective: June 7, 2023 Amended and Restated: October [●], 2023
12/34/56
EX-10.6
from S-4/A 10 pages Ambrx Biopharma, Inc. Amended and Restated 2021 Employee Share Purchase Plan Adopted by the Board of Directors: June 3, 2021 Approved by the Shareholders: June 9, 2021 as Amended and Restated as of October [•], 2023
12/34/56
EX-10.4
from S-4/A 30 pages Ambrx Biopharma, Inc. Amended and Restated 2021 Equity Incentive Plan Adopted by the Board of Directors: June 3, 2021 Approved by the Shareholders: June 9, 2021 as Hereby Amended and Restated, October [•], 2023
12/34/56
EX-10.2
from S-4/A 25 pages Ambrx Biopharma, Inc. Second Amended and Restated 2016 Equity Incentive Plan (As Amended and Restated Effective October [•], 2023) Article 1. Purpose
12/34/56